|
🐜
|
Involvement of Nuclear Factor-&kgr;B and Apoptosis Signal-Regulating Kinase 1 in G-Protein–Coupled Receptor Agonist–Induced Cardiomyocyte Hypertrophy
12 auth.
S. Hirotani,
K. Otsu,
K. Nishida,
Y. Higuchi,
T. Morita,
H. Nakayama,
...
O. Yamaguchi,
T. Mano,
Y. Matsumura,
H. Ueno,
M. Tada,
M. Hori
|
8 |
2002 |
8
🐜
|
|
🐜
|
Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart.
12 auth.
Kazuhiro Yamamoto,
T. Masuyama,
Y. Sakata,
N. Nishikawa,
T. Mano,
Junichi Yoshida,
...
T. Miwa,
M. Sugawara,
Yukihiro Yamaguchi,
T. Ookawara,
Keiichiro Suzuki,
M. Hori
|
7 |
2002 |
7
🐜
|
|
🐜
|
Activation of Matrix Metalloproteinases Precedes Left Ventricular Remodeling in Hypertensive Heart Failure Rats: Its Inhibition as a Primary Effect of Angiotensin-Converting Enzyme Inhibitor
8 auth.
Y. Sakata,
Kazuhiro Yamamoto,
T. Mano,
N. Nishikawa,
Junichi Yoshida,
M. Hori,
...
T. Miwa,
T. Masuyama
|
7 |
2004 |
7
🐜
|
|
🐜
|
A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial
71 auth.
W. Gray,
K. Keirse,
Y. Soga,
Andrew Benko,
A. Babaev,
Y. Yokoi,
Henrik Schroeder,
Jeffery T. Prem,
A. Holden,
J. Popma,
M. Jaff,
J. Diaz-Cartelle,
S. Müller-Hülsbeck,
T. Albrecht,
K. Ando,
...
M. Bacharach,
W. Bachinsky,
Danielle Bajakian,
Robert E. Beasley,
J. Benenati,
M. Burket,
Joseph Cardenas,
T. Das,
R. D. Martino,
H. Deutschmann,
D. Dulas,
R. Feldman,
Mark W. Fugate,
L. Garcia,
J. Golzar,
R. Gutta,
P. Hall,
S. Hawkins,
Steve Henao,
B. Herdrich,
K. Hirano,
Safwan Jaalouk,
S. Janzer,
D. Kawasaki,
Yazan Khatib,
K. Kichikawa,
E. Korngold,
C. Loewe,
Louis Lopez,
Henry H. Lui,
T. Mano,
R. Mendes,
A. Miyamoto,
Masato Nakamura,
David O’Connor,
T. Ohki,
James Park,
R. Powell,
Antonis Pratsos,
Jeffery T. Prem,
Vikram Rao,
John Rashid,
R. Rhee,
J. Ricci,
D. Scheinert,
H. Schroë,
P. O. Simon,
Gagan D. Singh,
K. Tan,
P. Tolerico,
Thodur M. Vasudevan,
F. Vermassen,
M. Werner,
B. Wiechmann,
H. Yokoi,
T. Zeller
|
7 |
2018 |
7
🐜
|
|
🐜
|
Development of different phenotypes of hypertensive heart failure: systolic versus diastolic failure in Dahl salt‐sensitive rats
12 auth.
R. Doi,
T. Masuyama,
Kazuhiro Yamamoto,
Y. Doi,
T. Mano,
Y. Sakata,
...
K. Ono,
T. Kuzuya,
Seiichi Hirota,
T. Koyama,
T. Miwa,
M. Hori
|
7 |
2000 |
7
🐜
|
|
🐜
|
Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy.
10 auth.
Hitoshi Yamaguchi,
Junichi Yoshida,
Kazuhiro Yamamoto,
Y. Sakata,
T. Mano,
N. Akehi,
...
M. Hori,
Y. Lim,
M. Mishima,
T. Masuyama
|
7 |
2004 |
7
🐜
|
|
🦁
|
Endothelial dysfunction in the early stage of atherosclerosis precedes appearance of intimal lesions assessable with intravascular ultrasound.
10 auth.
T. Mano,
T. Masuyama,
Kazuhiro Yamamoto,
J. Naito,
H. Kondo,
R. Nagano,
...
J. Tanouchi,
M. Hori,
M. Inoue,
T. Kamada
|
7 |
1996 |
7
🦁
|
|
🐢
|
Left atrial low-voltage areas predict atrial fibrillation recurrence after catheter ablation in patients with paroxysmal atrial fibrillation.
13 auth.
M. Masuda,
M. Fujita,
O. Iida,
S. Okamoto,
T. Ishihara,
Kiyonori Nanto,
T. Kanda,
T. Tsujimura,
Y. Matsuda,
S. Okuno,
...
T. Ohashi,
Aki Tsuji,
T. Mano
|
6 |
2018 |
6
🐢
|
|
🐜
|
AT1 Receptor Blocker Added to ACE Inhibitor Provides Benefits at Advanced Stage of Hypertensive Diastolic Heart Failure
10 auth.
Junichi Yoshida,
Kazuhiro Yamamoto,
T. Mano,
Y. Sakata,
N. Nishikawa,
Mayu Nishio,
...
T. Ohtani,
T. Miwa,
M. Hori,
T. Masuyama
|
6 |
2004 |
6
🐜
|
|
🐜
|
Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: Beneficial effects of mineralocorticoid receptor blocker.
13 auth.
T. Ohtani,
M. Ohta,
Kazuhiro Yamamoto,
T. Mano,
Y. Sakata,
Mayu Nishio,
Yasuharu Takeda,
Junichi Yoshida,
T. Miwa,
M. Okamoto,
...
T. Masuyama,
Y. Nonaka,
M. Hori
|
6 |
2007 |
6
🐜
|
